Introduction
Preconceptual dietary folic acid supplementation is known to reduce the incidence of NTDs in those having had a previous affected pregnancy (dose 5mgs/dayrelative risk 0.28, 95% Cl 0.21-0.71 (1) ) and in the general population (dose 0.4 mgs/day, relative risk 0.3, 95% Cl 0.1-0.6(2)). The best dose regimen is unknown. The neural tube is closed by 6 weeks menstrual age (4 weeks post-conception); treatment should therefore logically begin before conception.
On the basis of these findings several national health authorities have recommended an increased folic intake in those contemplating pregnancy (3, 4, 5) and all medical officers were requested to comply with these recommendations by the CMO (6) . Achieving the recommended intake is difficult without pharmaceutical support e.g. eight glasses of orange juice or 10 servings of broccoli per day would be required. Effective application of the recommendations could prevent 1000 NTDs/year in UK (7) .
The recommendations were reinforced by a letter from the consultant advisor in O&G to all SMOs in 1994 and by a further letter in the same year from the Senior Consultant in O&G in BFG emphasising the need for preconceptual administration. On 26 June 1995 a MA&TI was issued announcing the availability of Cantassium tabs (Folic acid 0.4 mgs, Larkhall Natural Health) in all NAAFI outlets. Medical personnel were instructed to ensure that this information was available to all women with the BFG.
Studies in UK have revealed poor compliance with the recommendations (8, 9) , not least because of initial limited availability of a suitable low-dose preparation and lack of awareness of the recommendations by primary health care workers. On 4 September 1995 an audit of compliance with these recommendations was commenced on women booking for antenatal care in British Military Hospital Rinteln.
Methods
BMH Rinteln is the only Military hospital east of the Rhine. All pregnant servicewomen and service dependents in that area book here, ideally between 18 and 20 weeks gestation. A questionnaire (Fig 1) was completed by the antenatal clinic midwife on all booking patients over a 12 week period. Answers were collated _ and analysed in Access l.l.
Results
One hundred and ninety nine women booked in the 12 week period. Gestational age range was 17 to 24 weeks (Mean 18.8 weeks).
Six had had a previous pregnancy affected by a NTD, their use of folic acid supplements is summarised in Table   l .
Awareness and use offolic acid in the remaining 193 is shown in Fig 2. Awareness of the benefit of folic acid supplementation was higher than expected (63.7%) but only 27.6% of these took the correct dose before conception (17.6% of all women). The major reasons for these were that many women remain unconvinced of the value of treatment and that those who were convinced took the correct dose but only after conception had occurred.
The influence of the source of information upon use of folic acid supplementation is shown in Table 2 .
Reasons for not taking folic acid at all despite awareness of its usefulness are listed in Table 3 .
Variations in successful patient education and compliance with time are shown in 
Discussion
The short interval between the publication of the MA & TI and the conception of these pregnancies limits the conclusions that can be made upon compliance with that document in particular. The medical profession should have been aware of the other recommendations for the use of folic acid, however, and forthcoming changes to the structure of antenatal care in BFG will make any such study more difficult in future. Some indication of use of folic acid supplementation is required before these changes occur. This audit suggests several problems with folic acid supplementation in BFG. The incorrect use of folic acid in 5/6 patients at highest risk is particularly disappointing. In part this may reflect post-conceptual presentation to the primary health care team, the questionnaire did not establish when women became aware of the benefits of supplementation. In the two cases where the lower (and possibly inadequate) dose was recommended by the primary health care team, it is fortunate (not least medicolegally) that a recurrence did not occur. Those at lower risk:-1. Are often unaware of the benefits of folic acid (36.3% of all bookers). 2. Do not consider the prevention of NTDs an important issue (35% of those aware of folic acid supplementation). 3. Do not find out about, or choose not to use, folic acid until after conception, by which time it is too late to be of any benefit (43.0% of those who took folic acid at all). The changes over the (admittedly short) study period indicate that those using folic acid may do so more effectively as time goes on (Fig 3) . If perfect usage was achieved amongst this group, however, this would still only account for 40.9% (79/193) of the population.
This situation can be improved via education or dietary fortification. Extensive patient education could improve awareness of the usefulness of folic acid supplementation but would have to be preconceptual. General practitioners have limited routine access to the healthy fertile woman. Opportunistic counselling at family planning, well woman and cervical smear clinics may be helpful particularly when combined with written information although only a minority of women are likely to be seen. Wider coverage could be achieved via the media which is currently as effective as community medical staff in communicating the need for preconceptual supplementation (Table 2) . This effect could be exploited via Garrison pUblications, Wives Club newsletters, SSVC and BFBS. Alternatively, routine fortification of food could be considered. Fortified bread is available (0.1 mgs/slice) and could be selectively purchased by NAAFI. Lobbying via the chain of command could encourage changes to the current government regulations regarding routine dietary fortification of staple foodstuff. In the long term the latter strategy is that most likely to be effective.
There are few occasions in clinical medicine whereby a practically harmless drug can be so certain to prevent such a catastrophe as a NTD, we should not waste the opportunity to use it effectively.
